She was noted to have a resting HR of 160.
ECG showed narrow-complex tachycardia at [**Street Address(2) 96583**] depressions in lateral leads.
Her BP was 132/90 mmHg.
She denied any chest pain, palpitaitons, diziness, lightheadedness, shortness of breath or any symptoms.
In the ER VS were T 97.5 F, BP 140/92 mmHg, HR 160 BPM, RR 18, SpO2 100% RA.
Patient did not respond to metoprolol 5mg IV x2 and then labetalol 10 mg IV x1; however her BP was always stable.
She dropped her blood pressure after propofol and received 1.2 L of NS.
Diabetes Mellitus type 2 - uncontrolled; last A1C 7.4 ([**Month (only) **] [**2104**]).
[**Doctor Last Name 933**] disease & thyroid nodules - TFT's WNL: free T4 1.2 and TSH 0.35 ([**2104-12-30**]).
Well-controlled SBP 100-130 mmHg.
Hypercholesterolemia - LDL 96, HDL 43, Chol 178, TG 197 on [**2104-11-28**] 6.
Osteoarthrosis 7.
Physical Exam: VITAL SIGNS - Temp 97.8 F, BP 100/60 mmHg, HR 120 BPM, RR 16 X', O2-sat 100% RA GENERAL - well-appearing woman in NAD, Oriented x3, comfortable, Mood, affect appropriate.
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear, Conjunctiva were pink, no pallor or cyanosis of the oral mucosa.
LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength [**3-31**] throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait PULSES: Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+, Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+   Pertinent Results: Admission Labs: [**2105-6-18**] WBC-11.5 Hgb-13.9 Hct-40.3 Plt Ct-256 PT-11.2 PTT-21.9 INR(PT)-0.9 Glucose-163 UreaN-26 Creat-1.2 Na-140 K-4.7 Cl-105 HCO3-24 CK(CPK)-87 cTropnT-<0.01 T4-6.3 T3-111 Free T4-1.4 TSH-0.057  ECHO [**2105-6-19**]: The left atrium is mildly dilated.
CXR [**2105-6-20**]: The heart is mildly enlarged and there is pulmonary vascular redistribution with small right pleural effusion and small areas of subsegmental atelectasis seen best on the lateral films.
Discharge Labs: [**2105-6-22**] WBC-11.2* RBC-3.75* Hgb-12.1 Hct-35.5* MCV-95 MCH-32.3* MCHC-34.1 RDW-14.2 Plt Ct-229 [**2105-6-23**] PT-30.8* PTT-32.2 INR(PT)-3.1* [**2105-6-23**] Glucose-160* UreaN-29* Creat-1.1 Na-140 K-4.3 Cl-106 HCO3-26 AnGap-12 [**2105-6-22**] Calcium-9.9 Phos-4.1 Mg-2.1 [**2105-6-18**] TSH-0.057* [**2105-6-18**] D-Dimer-427 [**2105-6-18**]  T4-6.3 T3-111 Free T4-1.4  Brief Hospital Course: # Rhythm - Patient with AFib with RVR in the setting of subclinical hyperthyroidism.
At discharge, her heart rates were approximately ******.
She did not convert to sinus rhythm during her admission.
INR monitoring was arranged with the [**Hospital 191**] [**Hospital 2786**] clinic prior to discharge.
She will need to repeat thyroid studies in approximately 2 weeks from discharge.
Her respiratory status improved with diuresis and her O2 sats were excellent on room air at discharge.
Echo showed normal wall motion, moderate MR, and mild pulmonary hypertension.
# Leukocytosis - Patient with an increased in white blood cell count to 20.7 (from 11.5 on admission).
She had negative urinalysis, blood cultures, and a chest xray that was not suggestive of infection.
HCTZ was held during this admission and on discharge to allow blood pressure room for heart rate control.
Cholecalciferol (Vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO once a day.
Rhinocort Aqua 32 mcg/Actuation Spray, Non-Aerosol Sig: [**11-28**] sprays Nasal twice a day.
Your heart rate was very fast and we started you on 2 new medicines to slow the rate down.
Because you have atrial fibrillation, you will need to be on coumadin to prevent blood clots and strokes.
Your goal INR is 2.0-3.0.
Phone:[**Telephone/Fax (1) 1803**] Date/time: Monday [**2105-7-27**] at 1 PM.
Date/Time:[**2106-3-31**] 10:00 Cardiology: Dr. [**First Name8 (NamePattern2) 449**] [**Last Name (NamePattern1) 437**] Phone: [**Telephone/Fax (1) 62**] Date/Time: [**2105-7-1**] at 10:30 am.
